I.A. Voutsadakis

Discipline

Psychologie (2) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (13) Recensions (2)

Co-auteur

Date

Source

Mot-clé

cancer (10) Cancer (10) Cancer (10) Methods (6) Proteins (6) Patients (6) Methods (6) Patients (6) Drama (5) survie (4) Treatment (4) Survival (4) Cancer cells (4) Breast (4) temps (durée) (3) papier (3) ADN (3) maladie (3) âge (3) Development (3) Inhibitors (3) Genes (3) Ubiquitin (3) Time (3) Theater (3) Prostate (3) Prognosis (3) Process (Law) (3) Paper (3) Expression (3)

Documents écrit par I.A. Voutsadakis (13) | parle de I.A. Voutsadakis (0)

Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides BRCA1 and BRCA2 as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies.
I.A. Voutsadakis et al.
Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.
I.A. Voutsadakis et al.
Statin use and peripheral blood progenitor cells mobilization in patients with multiple myeloma.
A. Stravodimou et al. (2014)
Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer.
A. Digklia et al. (2014)
Vinorelbine with or without Trastuzumab in Metastatic Breast Cancer: A Retrospective Single Institution Series
A. Stravodimou et al. (2014)
Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
A. Stravodimou et al. (2013)
Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer.
I.A. Voutsadakis (2013)
The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer.
I.A. Voutsadakis (2012)
The ubiquitin-proteasome system in glioma cell cycle control.
P.J. Vlachostergios et al. (2012)
Expression of neutral endopeptidase, endothelin-1, and nuclear factor kappa B in prostate cancer: interrelations and associations with prostate-specific antigen recurrence after radical prostatectomy.
P.J. Vlachostergios et al. (2012)
Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.
A. Stravodimou et al. (2012)
Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.
A. Patrikidou et al. (2012)
Inverse baseline expression pattern of the NEP/neuropeptides and NFκB/proteasome pathways in androgen-dependent and androgen-independent prostate cancer cells.
A. Patrikidou et al. (2011)